The Cova da Beira University Hospital Center is a Portuguese state-run hospital center in the Cova da Beira subregion.

During the past decade, Centro Hospitalar Cova da Beira conducted 10 clinical trials. In the 10-year time frame, 10 clinical trials started and 7 clinical trials were completed, i.e. on average, 70% percent of trials that started reached the finish line to date. In the past 5 years, 2 clinical trials started and 5 clinical trials were completed. i.e. 250% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Centro Hospitalar Cova da Beira" #1 sponsor was "Boehringer Ingelheim" with 5 trials, followed by "Bayer" with 2 trials sponsored, "Galapagos NV" with 2 trials sponsored, "Octapharma" with 2 trials sponsored and "Biogen" with 2 trials sponsored. Other sponsors include -2 different institutions and companies that sponsored additional 8 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Centro Hospitalar Cova da Beira" #1 collaborator was "Eli Lilly and Company" with 2 trials as a collaborator, "Gilead Sciences" with 2 trials as a collaborator and "Canadian Institutes of Health Research (CIHR)" with 1 trials as a collaborator. Other collaborators include -3 different institutions and companies that were collaborators in the rest 3 trials.

According to Clinical.Site data, the most researched conditions in "Centro Hospitalar Cova da Beira" are "Atrial Fibrillation" (3 trials), "Crohn's Disease" (2 trials), "Chronic Obstructive Pulmonary Disease" (1 trials), "Colitis, Ulcerative" (1 trials) and "Diabetes Mellitus, Type 1" (1 trials). Many other conditions were trialed in "Centro Hospitalar Cova da Beira" in a lesser frequency.

Most popular intervention types in "Centro Hospitalar Cova da Beira" are "Drug" (11 trials), "Device" (2 trials) and "Other" (2 trials). Other intervention types were less common.

The name of intervention was led by "Placebo" (3 trials), "Filgotinib" (2 trials), "Adalimumab" (1 trials), "Adalimumab placebo" (1 trials) and "Apixaban" (1 trials). Other intervention names were less common.

The vast majority of trials in "Centro Hospitalar Cova da Beira" are 14 trials for "All" genders and 1 trials for "Male" genders.

Currently, there are NaN active trials in "Centro Hospitalar Cova da Beira". undefined are not yet recruiting, 1 are recruiting, 1 are Active, not recruiting, and 1 are Enrolling by invitation. In total, there were 12 completed trials in Centro Hospitalar Cova da Beira, undefined suspended trials, and undefined terminated clinical trials to date.

Out of the total trials that were conducted in Centro Hospitalar Cova da Beira, 0 "Phase 1" clinical trials were conducted, 0 "Phase 2" clinical trials and 8 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 2 trials, and there were also 1 trials that are defined as “Not Applicable".